Drug information for BENOXINATE HYDROCHLORIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION/DROPS; OPHTHALMIC
0.4%
Discontinued
BENOXINATE HYDROCHLORIDE
benoxinate
SOLA BARNES HIND
84149
Drug Adverse Effects information for BENOXINATE HYDROCHLORIDE
Role code
Indications
Reaction
# Reports
C
AGE-RELATED MACULAR DEGENERATION
ATOPY
2
C
AGE-RELATED MACULAR DEGENERATION
ECZEMA EYELIDS
1
C
AGE-RELATED MACULAR DEGENERATION
EYE IRRITATION
2
C
AGE-RELATED MACULAR DEGENERATION
EYELID OEDEMA
2
C
AGE-RELATED MACULAR DEGENERATION
RETINAL DETACHMENT
2
C
AGE-RELATED MACULAR DEGENERATION
ULCERATIVE KERATITIS
2
C
LOCAL ANAESTHESIA
AGITATION
1
C
LOCAL ANAESTHESIA
BRADYCARDIA
1
C
LOCAL ANAESTHESIA
CYANOSIS
1
C
LOCAL ANAESTHESIA
DYSPNOEA
1
C
LOCAL ANAESTHESIA
HYPERSENSITIVITY
1
C
LOCAL ANAESTHESIA
OXYGEN SATURATION DECREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
AGITATION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BRADYCARDIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
CYANOSIS
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERSENSITIVITY
1
C
PRODUCT USED FOR UNKNOWN INDICATION
OXYGEN SATURATION DECREASED
1
C
PROPHYLAXIS
AGITATION
2
C
PROPHYLAXIS
BRADYCARDIA
2
C
PROPHYLAXIS
CYANOSIS
2
C
PROPHYLAXIS
DYSPNOEA
2
C
PROPHYLAXIS
HYPERSENSITIVITY
2
C
PROPHYLAXIS
OXYGEN SATURATION DECREASED
2
C
RETINAL VEIN OCCLUSION
ENDOPHTHALMITIS
2
Ads by Google